MarketPulse

geographic atrophy

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Annexon to Present Pivotal Data Catalyst at Major Healthcare Conference

$ANNX set to showcase ARCHER II Phase 3 results targeting $1B+ geographic atrophy market at BofA Securities conference May 2026.
ANNXclinical trialbiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Apellis to Highlight Complement Science Portfolio at TD Cowen Healthcare Forum

Apellis will discuss its complement-targeted drug portfolio at TD Cowen Healthcare Forum in March 2026, highlighting its approved therapies for eye and kidney diseases.
APLSbiopharmaceuticalApellis Pharmaceuticals